Delivery Order SPE2DE24D0013-SPE2D625F3JEQ

The U.S. Department of Defense's Medical Supply Chain awarded a $3,272 firm fixed-price delivery order to Cepheid Inc. on September 12, 2025, with an ultimate completion date of September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems and test kits, will fulfill this order without a set-aside designation. The company's GeneXpert diagnostic platform and associated reagents represent its core product offering for federal healthcare applications.

This delivery order likely derives from one of Cepheid's two significant Indefinite Delivery Vehicle contracts with the Veterans Health Administration, including the Veterans Integrated Service Network 21 contract valued at $2.5 million, which specifically covers polymerase chain reaction testing for infectious diseases including COVID-19, influenza, and RSV. Cepheid has established itself as a critical supplier to multiple federal agencies, including the Department of Veterans Affairs and Defense Logistics Agency, providing comprehensive molecular diagnostic capabilities across the federal healthcare system. The modest ceiling value of this particular delivery order reflects a routine procurement request within the broader framework of these larger IDV vehicles that enable continuous procurement of diagnostic solutions.